Logo Lanfrica

Data from: Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum

Domaine:

healthcare

Type de record:

dataset
Créateur:
BusMorDuaQua
Éditeur:
Dry
Hôte:avatar
Infections with the malaria parasite Plasmodium falciparum typically comprise multiple strains, especially in high-transmission areas where infectious mosquito bites occur frequently. However, little is known about the dynamics of mixed-strain infections, particularly whether strains sharing a host compete or grow independently. Competition between drug-sensitive and drug-resistant strains, if it occurs, could be a crucial determinant of the spread of resistance. We analyzed 1,341 P. falciparum infections in children from Angola, Ghana, and Tanzania and found compelling evidence for competition in mixed-strain infections: overall parasite density did not increase with additional strains, and densities of individual strains (chloroquine-sensitive and chloroquine-resistant) were reduced in the presence of competitors. We also found that chloroquine-resistant strains exhibited low densities compared to chloroquine-sensitive strains (in the absence of chloroquine), which may underlie observed declines of chloroquine resistance in many countries following retirement of chloroquine as a first-line therapy. Our observations support a key role for within-host competition in the evolution of drug-resistant malaria. Malaria control and resistance-management efforts in high-transmission regions may be significantly aided, or hindered, by the effects of competition in mixed-strain infections. Consideration of within-host dynamics may spur development of novel strategies to minimize resistance while maximizing the benefits of control measures. Bushman DataThis folder includes all data necessary to reproduce the reported findings. Some files overlap in content but are formatted to facilitate analysis (R code at github.com). Data include parasitemia, genotype, age, location, year of sample collection, microsatellite genotyping results, MOI frequencies, and certain controls used to correct results for mixed-genotype infections.

Similaires